Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Allergy Medicine
Human Trials Of New Vaccine Technique Prove Promising For Allergy Sufferers
April 11th, 2001
For years, efforts to develop improved vaccines for asthma and allergies have been thwarted because the vaccines themselves often cause the very symptoms a person is trying to avoid. At the 57th Annual American Academy of Allergy, Asthma, and Immunology's meeting held in March 2001, researchers at Johns Hopkins announced that a novel method of modifying an allergen, such as ragweed, by attaching a synthetic piece of DNA to it, is showing promise in initial clinical trials. The finding may lead to a more effective vaccine for treating allergic diseases such as hay fever or asthma. "This initial study shows that the vaccine can produce IgG...
Source: Vaccine Weekly (2001-04-11)
|
